Presentation TCT 2012

FAME 2 Cost-effectiveness: A Prospective, Randomized Trial Evaluating the Cost-effectiveness of FFR-Guided PCI in Patients with Stable Coronary Artery Disease

Presenter: William Fearon

REGISTER for free or LOG IN to view this content

FAME 2 Cost-effectiveness: A Prospective, Randomized Trial Evaluating the Cost-effectiveness of FFR-Guided PCI in Patients with Stable Coronary Artery Disease
FFR
Presentation
TCT 2012

Up Next

More slides +

We Recommend